Evidence map›Paper›PMID 41136487›Full record

ArticleScientific reports2025

Long-term exposure to ambient air pollution and cardiometabolic multimorbidity in Chinese adults over 45 years.

Ruikang Liu, Guangyi Yang, Chiyun Sun, Jun Li, Wenjie Zhang, Xuanchun Huang, Chao Meng, Yiying Liu, Lilan Su, Hanyu Jiang and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruikang Liu *Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Guangyi Yang *Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Chiyun Sun *Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Jun LiGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. gamyylj@163.com.
Wenjie ZhangGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Xuanchun HuangGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Chao MengGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yiying LiuGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Lilan SuGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Hanyu JiangGraduate School, Beijing University of Chinese Medicine, Beijing, China.
Tiantian XueGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. 15776760213@163.com.

Funding

Major Achievement Guidance Project of Chinese Medicine Science and Technology, China Academy of Traditional Chinese Medicine - Clinical and Mechanistic Study of Warm-Yang and Activate Blood Formula for the Treatment of Post-Infarction Heart Failure ZZ13-ZD-04National Natural Science Foundation of China Supervised Project - Exploring the mechanism of action of Stabilising Heart Soup in inhibiting post-infarction ventricular remodelling based on the mitochondrial autophagy-dependent iron death FUNDC1-GPX4 axis 82474494Research and Development Special Project on Advantageous Diseases-Hospital Preparations-New Drugs of the China Academy of Traditional Chinese Medicine-Development of a Traditional Chinese Pharmaceutical Preparation for Treating Angina Pectoris of Coronary Heart Disease Due to Qi Deficiency and Blood Stasis-Stabilising Heart Soup ZZ15-XY-CT-08
6 · The paper itself

Abstract

The rising prevalence of cardiometabolic multimorbidity (CMM), characterized by the coexistence of two or more cardiometabolic disorders, poses a significant public health challenge in aging populations. While ambient air pollution is a recognized environmental risk factor, its long-term impact on CMM remains underexplored, particularly in China. Utilizing data from the China Health and Retirement Longitudinal Study (CHARLS, 2015 wave), we analyzed 9,830 participants aged ≥ 45 years. CMM was defined as the concurrent presence of two or more conditions: diabetes/hyperglycemia, cardiovascular diseases (myocardial infarction, angina pectoris, coronary artery disease, or heart failure, or stroke. Annual pollutant exposures were estimated using a machine learning-based spatiotemporal model (space-time extremely randomized trees) based on residential addresses. Generalized linear models adjusted for sociodemographic, lifestyle, and meteorological covariates were employed to assess odds ratios (ORs) per interquartile range (IQR) increase in pollutants. Chronic exposure to particulate matter (PM) 10 demonstrated a consistent positive association with CMM prevalence across models. In fully adjusted analyses, each IQR increase in PM10 was associated with elevated CMM risk (OR = 1.01, 95% CI: 1.00-1.02, P = 0.039). Sensitivity analyses, including alternative exposure windows and adjustments for regional variations, reinforced PM10's robust association with CMM. Other pollutants (PM2.5, and sulfur dioxide) showed weaker or inconsistent associations. Long-term exposure to ambient particulate matter, particularly PM10, is significantly linked to increased CMM prevalence in China's aging population. The findings of this study provide epidemiological evidence, laying the foundation for future cohort studies and mechanistic investigations.

Indexed as

Air PollutionCardiovascular DiseasesEnvironmental ExposureMultimorbidityAgedAir PollutantsChinaEast Asian PeopleFemaleHumansLongitudinal StudiesMaleMiddle AgedParticulate MatterPrevalenceRisk FactorsAir PollutantsParticulate Matter2015 CHARLSAmbient air pollutantsCardiometabolic multimorbidityElderlyRemote sensing

Identifiers

PMID41136487
PMCPMC12552661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.